Zlatan Mujagić

30PUBLICATIONS
68CO-AUTHORS
Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyExercise physiologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 04, 2026
Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry.

Loriane M M Verleye, Marieke J Pierik, Annemarie C de Vries

|Dec 05, 2025
Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry.

M R Naber, A E van der Meulen, P W Voorneveld

|Dec 02, 2025
Irritable bowel syndrome-specific volatile organic compounds in faecal headspace do not associate with classical symptom-based subtypes.

R Van Vorstenbosch, M Skawinski, D Jonkers

|Oct 08, 2025
Health-Related Physical Fitness in Patients With Inflammatory Bowel Disease vs Healthy Control Subjects.

Karlijn Demers, Noortje van den Bergh, Bart C Bongers

|Jul 27, 2025
Comprehensive Motility Analysis in Patients with Hypermobility Spectrum Disorders and Gastrointestinal Symptoms: An Exploratory Tertiary Care Study.

Kim W E Sweerts, Lisa Vork, Zlatan Mujagic

|Jul 08, 2025
The Risk of Mild, Moderate, and Severe Infections in IBD patients - A prospective, multicentre observational cohort study (PRIQ).

Ashkan Rezazadeh Ardabili, Dirk Van Esser, Dion Wintjens

Pageof 5

Frequent Collaborators

9 joint publications

Daniel Keszthelyi

7 joint publications

Lisa Vork

7 joint publications

Marieke Pierik

4 joint publications

Ashkan Rezazadeh Ardabili